Pfizer in Global Blood Therapeutics Takeover Talks
2022.08.05 19:22
Pfizer (PFE) in Global Blood Therapeutics Takeover Talks
By Sam Boughedda
Pfizer (NYSE:PFE) is reportedly in talks to acquire Global Blood Therapeutics Inc (NASDAQ:GBT), according to a report by The Wall Street Journal Friday.
The news follows Thursday’s report by Bloomberg that large pharmaceutical companies are eyeing a potential takeover deal for Global Blood Therapeutics.
Pfizer is said to be discussing a potential $5 billion takeover of Global Blood Therapeutics. The company’s drug for sickle-cell disease was recently approved. The move would bolster Pfizer’s portfolio and pipeline.
The WSJ said its sources told them Pfizer is aiming to seal a deal for GBT within the coming days. However, there is no guarantee of a deal, and other companies are said to be “still in the mix.”
GBT shares popped 41% following Thursday’s report and have gained another 9.5% Friday.
